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Equipment Design Issues for the In Vivo
X-Ray Fluorescence Analysis of Bone
Lead
by Brian J. Thomas*
Several groups have reported the development ofsystems, based on the principle ofX-ray fluores-
cence, for the in vivo measurement ofbone lead concentrations. These systems have used the detec-
tion ofeither the characteristic L or K X-rays resulting from excitation by a suitable photon source.
This paper examines design issues related to the development ofthese systems. These design issues
are, in most instances, a result ofconsideration ofthe physical principles involved, and hence there
are many features comunon to the systems developed by the individual groups. Design issues dis-
cussed in this paper include the selection ofthe site for measurement, source-sample-detector con-
figuration, and collimation. Speciflc examples from published work are used to demonstrate the
relevant features.
Introduction
In vivo X-ray fluorescence (XRF) analysis provides a
method ofmeasuring the concentration oflead in spe-
cific sites ofthe skeleton which, in the adult, contains
approximately 90% ofthe whole body lead burden (1).
Systems developed for this purpose have used excita-
tionanddetection ofeitherthe characteristic L or K X-
rays of lead. The relatively low energy ofthe photons
involved using either technique imposes a limitation
on the bony sites that can be measured because ofthe
strong attenuation of both the incident and emitted
photons. This is particularly the case for the system
using excitation and detection of L X-rays.
The intensity ofcharacteristic lead X-rays excited is
relatively low, particularly whenbone lead concentra-
tions in the normal range (10-20 ppm) are being mea-
sured. The limiting factor to the lower limit of detec-
tion is the contribution of this background radiation
impinging upon the detector. The major contribution
to the background is from source photons, which are
Compton-scattered in the sample and/or in the detec-
tor assembly. In order to reduce this background con-
tribution, consideration needs to be given to the
source-detector configuration and to limiting the
range ofdetection anglesbythe use ofcollimation. De-
sign issues, resulting from consideration of these fac-
tors, are discussed in the following sections.
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Design Issues
General System Features
There have been three basic designs reported in the
literature for the in vivo measurement oflead in bone
byXRFanalysis. Twoofthese use excitation anddetec-
tionoftheKX-raysofleadandthethirdusesexcitation
and detection ofthe L X-rays(2). The significant differ-
ence between the two K X-ray techniques isthe excita-
tion source employed: either '09Cd (3) or 57Co (4,5). The
selection of a particular excitation source imposes
restraintsonthe design,principally intermsofsource-
detectorconfiguration. Schematicdiagramsofsystems
using the three approaches are given in Figure 1. De-
tails ofsources anddetectors used are given in Table 1.
Selection of the Source for Excitation
In consideration of the efficiency of excitation, the
source should emit photons, ideally, ofenergy slightly
above the K(orL) shell absorption edge (88 keV and 16
keV, respectively). However, in selecting a source, con-
sideration needs also to be given to the half-life, avail-
ability, and cost ofthe excitation source as well as dif-
ficulties related to potential background from trans-
mitted or scattered source photons. In addition, and
particularlyforthe LX-raytechnique,thepenetration,
or more particularly, the attenuation, of the incident
photons is an important consideration.
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FIGURE 1. Schematic diagrams to illustrate the three basic designs of systems developed for the in vivo measurement of bone lead con-
centrations by XRF analysis. (A) A system using detection ofL X-rays (2). (B) A system using detection ofK X-rays and using 1°9Cd as
an excitation source (3). (C) A system using detection ofK X-rays and using 57Co as an excitation source (5); this system is very similar
to that described Ahlgren and Mattsson (4).
Ihble 1. Typical source and detector details for in vivo X-ray fluorescence bone lead systems.
System
la 2b 3C
Source
Isotope 125I 10Cd 57Co
Unit activity 3.7 3.7 (annular) 2 times 1 unit activity
Energy ofphotons emitted, keV 27, 31, 36 88 122 (and others)
X-rays detected L K K
Detector
Type Si (Li) Ge Ge
Dimensions 80 mm2 x 2 mm 16 mmD x 7
mm 25 mmD x 7 mm
Resolution 200 eV at 5.9 keV 480 eV at 75 keV 450 eV at 75 keV
Source-detector configuration -900 -180° -900
a System 1 used by Weilopolski et al. (2).
b System 2 used by Somervaille et al. (3).
c System 3 used by T.hlgren and Mattsson (4) and Price et al. (5).
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FIGURE 2. The relative detection efficiency for lead as a function ofdepth in appropriate phantoms.
geometry (3); (B) using a 57Co source and 900 geometry.
gamma ray (35.5 keV), was the source used by Wielo-
polski et al. for the excitation ofL X-rays (2). The rela-
tive intensities ofthe three photons is 1.0, 0.2, and 0.6,
respectively. The photons emitted by this source are
somewhat higher in energy than those required for
maximum excitation ofthe L X-rays of lead. However,
the use of lower energy photons for excitation would
accentuate problems related to attenuation ofthe pri-
mary beam, e.g., the 99% sampled depth using 125I is
2.8 mm in bone, which would be reduced to approxi-
mately 2.5 mm if, for example, Ag X-rays (22 and 25
keV) from a '09Cd source were used for excitation. Cor-
rections need to be made for attenuation due to overly-
ing soft tissue as each millimeter ofsoft tissue results
in reduction ofthe intensity ofthe L X-raysby approxi-
mately 25%. Application ofthese corrections requires
an estimate ofsoft tissue thickness. Wielopolski et al.
(2)used ultrasound techniques for this estimation. The
uncertainty in this ultrasound technique was 0.3
mm. This contributes an uncertainty of about 10%
tothe estimation ofthe lead concentration in the bone.
109Cd and 57Co have been used to excite the charac-
teristic K X-rays of lead. As discussed later, different
source-detector configurations must be employed: 1800
(i.e., "backscatter") when using 109Cd, and 900 when
using 57Co. `09Cd (Ey = 88 keV) provides more efficient
(A) Using a '09Cd source in backscatter
excitation compared with 57Co (E-y = 122, 136 keV and
others). When using a 109Cd source, a thin (0.5 mm)
copper foil must be placed in front ofthe source to re-
duce the total count rate resulting from Ag X-rays
emitted by the source (Fig. 1B).
57Co has the slight disadvantage that higher energy
gamma rays(up to 707 keV) are also emitted, although
at low intensities. Thus, thicker collimators are re-
quired. Both sources are similarin cost perunit activi-
ty and typically need to be replaced at approximately
2- to 3-year intervals, although this period can be ex-
tended iflonger measurement times can be tolerated.
Selection of Measurement Site
Both types of systems, i.e., using detection of either
K or L X-rays, involve relatively low energy incident
and emitted photons and hence are limited to mea-
surement of lead in superficial bony sites. In this re-
spect the system using excitation and detection ofthe
L X-rays has been applied only to measurement ofthe
cortical region ofthe tibia where the overlying tissue
is sufficiently thin (2-3 mm) so that the low energy
photons have adequate penetration. Even so, the
strong attenuation ofthe photons limits the measure-
ment to a sampled depth ofapproximately 2.8 mm. To
A
41B. J THOMAS
A
Photon energy (keV)
B
FIGURE 3. Typical spectra obtained in the K X-ray technique. (A) Using '09Cd as an excitation source and a backscatter geometry (3); (B)
Using 57Co as an excitation source and a 90° geometry (4).
assist comparison with the K X-ray technique, it is
worth noting that the depth at which the sensitivity
decreases to 30% is approximately 1.3 mm in the L X-
ray technique. This limitation may be an advantage in
some ways as it is lessthanthe cortical bone thickness
and therefore results in a measurement involving a
reasonably constant mass of bone (2). However, the
strong attenuation of the photons remains a major
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concern in the application ofthe L X-ray technique.
Systems using excitation and detection of K X-rays
are less subject to this limitation; however, the pene-
tration is such that the sensitivity is reduced to ap-
proximately 30% at sites approximately 25 mm from
the surface (Fig. 2). Systems using the K X-rays have
been used for measurement of lead in sections of the
phalanx ortibiaandpotentiallycouldbeusedforother
bony sites.
When the phalanx is the site chosen for measure-
ment, bilateral irradiation will significantly improve
the variation in sensitivity with depth in tissue. In
theory, rotating the finger (by 1800) for halfthe mea-
surement time in a bilateral irradiation facility will
produce a measurement that is relatively position in-
sensitive-at least within the 1 cm length ofthe pha-
lanx studied.
Source-Detector Configuration
In systems using the detection ofK X-rays, the prin-
cipal limitation on sensitivity is the magnitude and
width of the broad peak in the spectrum resulting
from source photons Compton-scattered in the sample
(Fig. 3).
Considerations of the energy and intensity of the
Compton-scattered photons indicate that source and
detector shouldbe arranged at 1800 for a system using
a 109Cd source and 900 for a system using a 57Co source.
A single scatter of a-122 keV (57Co) photon cannot
overlap the Kca1 X-ray energy of75 keV no matter how
large the scattering angle. However, scattering ofpho-
tons within the detector assembly itself produces a
broad, low-energy tail to the spectrum which overlaps
the K X-ray energies of lead (6) (Fig. 3B). This is the
most important factor determining the lower limit of
detection. The magnitude ofthis effect can be reduced
usingcollimationofboththe sourcephotonsandonthe
detector face to limit the possible angle ofsource pho-
tonsscatteredintothedetector andsothatthedetector
views only the irradiated volume. Reducing the dia-
meter ofthe collimator reduces the effect due to scat-
teredradiation but also reducesthe efficiency ofdetec-
tion ofthe excited characteristic X-rays. Collimation of
0.7 to 1.0 cm provides a compromise between the two
effects.
The backscatter geometry used in a 109Cd system is
best achieved with an annular source as shown in
Figure 1B. The collimator is designed to limit the pos-
sible angle ofsource photons scattered into the detec-
tor to the range 140 to 1800 (approximate). Use ofthis
arrangement provides a better signal-to-noise ratio
than obtained with the 57Co system and hence a some-
what lower limit of detection.
In both K X-ray designs, tungsten (or other heavy
metal)isusedasthecollimatingmaterial. Shieldingis
less ofa problem with an 125I source in an L X-ray sys-
tem because of the (very) low energy of the photons
used. Light and relatively thin materials can be used.
Wielopolski et al. (2)used a900 source-detector geome-
try. However, the backscatter geometry should also be
applicable if the 125I source is available in annular
form. As with the K X-ray systems, collimation is de-
signed to reduce the intensity of the detected Comp-
ton-scattered photons.
Conclusion
Some ofthe design issues related to development of
systemsforthe in vivo measurement ofbone leadby X-
ray fluorescense analysis have been discussed. As
mentioned earlier, these design issues are a result of
consideration of the physical principles involved,
mainly in respect to Compton scatter of source pho-
tons, attenuation of source, and emitted photons and
detector response. The successful application of the
methods discussed permits the in vivo measurement
ofbone leadconcentrations at and above normal levels.
Development ofa suitable system isfirst determined
by a decision astothebony site tobe measured. Ifonly
the cortical layer ofa (superficial) bone is to be exam-
ined, then the L X-ray method must be employed. Ifit
is considered important to involve larger volumes of
bone inthemeasurement,thenaKX-raymethodmust
be used. As Wielopolski et al. have noted (2), "the two
measurements complement each other," and at this
stage provide the only methods ofmeasurement ofthe
leadconcentration inaselectedbonysite. Whetherthe
results ofthese measurements canbe used as an index
of total body lead burden requires further investiga-
tion. In this respect, development of systems capable
of sampling, in a reasonable time, larger volumes of
bone and possibly at less superficial sites needs to be
considered.
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